ePatient / Health 2.0 - A Key Factor for New and Innovative Business Models for the Life Sciences Industry

17 November 2011, Düsseldorf, Germany.
InterComponentWare AG (ICW), an internationally focused company specializing in technology solutions for the healthcare market, invites to a podium discussion during the Medica Media Forums. Follow the newest discussions at Medica 2011 in Düsseldorf and take advantage of the opportunity to discuss with subject matter experts. ICW representatives are looking forward to meeting you at 3:00 pm on Thursday, 17th November 2011 at the MEDICA Media Forum in Hall 15 (Stand A11).

Today's patients are well informed and capable of making their own decisions when it comes to healthcare. When making their decisions about health products and services they utilize both real-world channels and electronic channels of the internet. Increasingly, the "ePatient" is becoming a factor in the "Health 2.0 ecosystem".

ICW develops innovative solutions for the healthcare system under the slogan "connect. manage. personalize." Get a new perspective and discover how solutions from ICW can help you to network disparate actors, support care-critical processes, and create options for modern interaction to engage the patient in the treatment process.

Take time to visit ICW at MEDICA in Hall 15, Stand F35 to get an interesting look at modern eHealth solutions.

Arrange a personal appointment here: http://www.icw-global.com/en/press-events/medica-appointment.html, or send an email to Mr. Silvio Frey This email address is being protected from spambots. You need JavaScript enabled to view it.
Upon request ICW representatives will also gladly send complementary admission tickets or informational material.

About ICW
ICW is an international healthcare technology provider. Our robust software and techniologies help to network the various actors, optimize care and engage patients in the treatment process. Our products are based on the ICW eHealth Platform, a suite of powerful technology components that support the quick assembly of eHealth solutions and the flexible implementation of integration scenarios. Together with our partners, our goal is to enable interoperability among healthcare stakeholders to harvest potentials and realize innovative forms of cooperation and collaboration. For more information go to www.icw-global.com.

Most Popular Now

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...

500,000 missed out on blood pressure lowering drug…

Nearly half a million people missed out on starting medication to lower their blood pressure during the COVID-19 pandemic, according to research supported by the British ...